Skip to main content

Table 1 Patient characteristic

From: Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials

 

MA.20[16]

EORTC[17]

French[15]

Recruitment years

2000-2007

1996-2004

1991-1997

Number of patients

1832

4004

1334

Median age

54

54

57

Node positive

85%

56%

75%

Breast surgery

100% breast conserving

75% breast conserving

100% mastectomy

CHX

91%

85%

61%

ER/PR negative

25%

16%

7%

Unknown ER/PR status

n.a.

6%

40%

Main inclusion criteria

N + or high risk* N0 any location

N + or medial/central tumor

N + or medial/central tumor

Breast/chest wall

Both arms: 50 Gy / 25 fx

Both arms 50 Gy / 25 fx

Both arms according to practice of the center

Medial supraclavicular nodes

Experimental arm: 45 Gy / 25 fx

50 Gy / 25 fx

All patients: dose and fractionation according to practice of the center

Internal mammary nodes

Experimental arm: 45 Gy / 25 fx

Experimental arm: 50 Gy / 25 fx

Experimental arm: 45 Gy / 20 fx

  1. *= > = 5 cm tumor, > = 2 cm tumor, and <10 axillary nodes removed with ER-, G3, or lymph vacular invation; n.a. = not available; fx = fractions; ER = estrogene receptor; PR = progesterone receptor.